Thyroid dysfunction in 85-year-old men and women. Influence of non-thyroidal illness and drug treatment.
Serum TSH and free T4 were determined by chemiluminometric assays in 601 women and 285 men aged 85 years from the population study "70-year-old people in Gothenburg, Sweden". For individuals with serum TSH concentration above 6.0 mU/l, "antimicrosomal" antibodies were determined, to assess the etiology of the elevated TSH concentration. Clinical follow-up was done of survivors until the age of 88, and records were inspected also for individuals who died before that age. On the basis of these evaluations the prevalence of previously undetected hypothyroidism was estimated to 4.0% in women and 2.5% in men. Previously undetected hyperthyroidism was found in 2, at the most 4, out of 601 women; in one out of 285 men the diagnosis could not be excluded. Possible confounding factors for the evaluation of TSH and/or free T4 concentrations were analysed by permutation t-test followed by multiple regression analysis, which revealed correlations of log TSH concentration to body mass index (p less than 0.05), serum creatinine concentration (p less than 0.05), and diabetes mellitus (inverse relationship, p less than 0.01). Correlation was found of free T4 concentration to treatment with non-selective beta-blocking agents (p less than 0.001) and digitalis glycosides (p less than 0.01). However, none of the factors influencing TSH and/or free T4 concentrations had any major influence on reference limits, nor could they account for individuals with "out-lier" values.
Sundbeck
G
G
Department of Geriatric and Long-Term Care Medicine, Vasa Hospital, Gothenburg, Sweden.
Edén
S
S
Jagenburg
R
R
Lindstedt
G
G
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D015992:Body Mass Index; D003401:Creatine / Q000097:blood; D004071:Digitalis Glycosides / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000097:blood / Q000188:drug therapy / Q000453:epidemiology; D007037:Hypothyroidism / Q000097:blood / Q000188:drug therapy / Q000453:epidemiology; D008163:Luminescent Measurements; D008297:Male; D015995:Prevalence; D013548:Sweden / Q000453:epidemiology; D013959:Thyroid Diseases / Q000097:blood / Q000188:drug therapy / Q000453:epidemiology*; D013961:Thyroid Gland / Q000503:physiopathology*; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood
D000319:Adrenergic beta-Antagonists; D004071:Digitalis Glycosides; D013972:Thyrotropin; D003401:Creatine; D013974:Thyroxine